待处理
入排:排除
图源:待检查
The added value of Bayesian interim analysis in randomized phase II and phase III clinical trials in hemato-oncology.
Anna J T Smit, Niek G Van der Maas, Bronno Van der Holt, Yvette Van Norden, Erik Van Werkhoven, Annette Juul Vangsted, Paula F Ypma, Heleen A Visser-Wisselaar, Rossella Troia, Mario Boccadoro, Bob Löwenberg, Jeroen J W M Janssen, Gert J Ossenkoppele, Fredrik Schjesvold, Pieter Sonneveld, Sonja Zweegman, Jurjen Versluis, Jan J Cornelissen
Haematologica 111(3) 1105-1110
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板